Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Do kidney disease or diabetes change how long nerve blocks last?

NCT ID NCT01323075

Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at how long nerve blocks last in people with kidney failure or diabetes compared to those without these conditions. Researchers gave 120 patients a truncal block during hand or wrist surgery and measured when sensation returned. The goal was to see if metabolic diseases affect nerve block recovery time.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
truncal block (nerve block procedure)
What this could lead to
If successful, this could help doctors predict how nerve blocks work in patients with kidney failure or diabetes, leading to safer and more effective pain management.
What could go wrong
This is a small, completed study focused on measuring nerve block duration, not on developing a new treatment. Results may not apply to all patients or surgeries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

120 people

The number who actually took part.

Start date

May 2011

Finished

Dec 2013

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Three patient populations schelduled for surgery on the hand or wrist. The three groups include (1) patients with no metabolic or neurologic disease history, (2) patients with renal insufficiency but not diabetes and (3) patients with diabetes but not renal insufficiency.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

General Inclusion Criteria: * The patient must have given his/her informed and signed consent * The patient must be insured or beneficiary of a health insurance plan * The patient is available for 1 month of follow up * The patient is scheduled for hand or wrist surgery Inclusion Criteria for the "Renal Insufficiency" group * Patient has renal insufficiency as defined by a creatine clearance of \< 30ml/min without dialysis Inclusion Criteria for the "Diabetes" group * Patient has chronic hyperglycemia, either a fasting glycemia \> 1.26 g/l (7mmol/l) for longer than 5 years and receiving an oral, well-adjusted (last HBA1c \< 6.5%)), non-insulin, antidiabetic treatment Inclusion Criteria for the "Non-exposed" group * Patient without metabolic or neurologic disease, with creating clearance \> 90ml/min Exclusion Criteria: * The patient is participating in another study * The patient is in an exclusion period determined by a previous study * The patient is under judicial protection, under tutorship or curatorship * The patient refuses to sign the consent * It is impossible to correctly inform the patient * The patient is pregnant * The patient is breastfeeding * Patient weighs less than 50 kg * Score ASA \> 4 * contra indication for locoregional anesthesia * Severe metabolic and / or decompensated renal disease, cardiac or pulmonary decompensation * Associated peripheral neuropathy associated with diabetes or kidney disease * Associated central neuropathy associated (eg MS ... narrow cervical canal) * Patients with both renal failure and diabetes

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetes mellitus kidney failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes Renal insufficiency

Contacts and locations

Locations

  • Centre Hospitalier Universitaire de Nîmes

    Nîmes, Gard, 30029, France

  • Hôpital Lapeyronnie CHU de Montpellier

    Montpellier, 34295, France

  • Hôpital Privé Claude Galien

    Quincy-sous-Sénart, 91480, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.